Medical Supply Chain Resiliency Act aims to enhance U.S. medical supply chain resilience by negotiating trade agreements with trusted partners.

The Medical Supply Chain Resiliency Act seeks to bolster the U.S. medical supply chain by authorizing the President to negotiate trade agreements with trusted partners. These agreements aim to eliminate trade barriers, diversify supplier networks, and improve overall supply chain resilience. The Act emphasizes the importance of international collaboration, research and development, and regulatory cooperation to ensure a reliable supply of medical goods. It also mandates regular reporting to Congress on the status of negotiations and compliance with these agreements.

Medical Supply Chain Resiliency Act aims to enhance U.S. medical supply chain resilience by negotiating trade agreements with trusted partners.

The Medical Supply Chain Resiliency Act seeks to bolster the U.S. medical supply chain by authorizing the President to negotiate trade agreements with trusted partners. These agreements aim to eliminate trade barriers, diversify supplier networks, and improve overall supply chain resilience. The Act emphasizes the importance of international collaboration, research and development, and regulatory cooperation to ensure a reliable supply of medical goods. It also mandates regular reporting to Congress on the status of negotiations and compliance with these agreements.